BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 9773251)

  • 1. Heparin-induced thrombocytopenia and thrombosis.
    Arepally G; Cines DB
    Clin Rev Allergy Immunol; 1998; 16(3):237-47. PubMed ID: 9773251
    [No Abstract]   [Full Text] [Related]  

  • 2. Heparin-induced thrombocytopaenia.
    Gounden R; Blockman M
    Cardiovasc J Afr; 2008; 19(6):325-7. PubMed ID: 19104731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re-exposure to heparin in uremic patients requiring hemodialysis with heparin-induced thrombocytopenia.
    Wanaka K; Matsuo T; Matsuo M; Kaneko C; Miyashita K; Asada R; Matsushima H; Nakajima Y
    J Thromb Haemost; 2010 Mar; 8(3):616-8. PubMed ID: 20050999
    [No Abstract]   [Full Text] [Related]  

  • 4. Heparin is not required for detection of antibodies associated with heparin-induced thrombocytopenia/thrombosis.
    Visentin GP; Moghaddam M; Beery SE; McFarland JG; Aster RH
    J Lab Clin Med; 2001 Jul; 138(1):22-31. PubMed ID: 11433225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The identification and management of heparin-induced thrombocytopenia in the vascular patient.
    LaMuraglia GM; Houbballah R; Laposata M
    J Vasc Surg; 2012 Feb; 55(2):562-70. PubMed ID: 22188737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin-Induced Thrombocytopenia: A Focus on Thrombosis.
    Arepally GM; Padmanabhan A
    Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):141-152. PubMed ID: 33267665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed-onset heparin-induced thrombocytopenia and thrombosis.
    Ann Intern Med; 2001 Oct; 135(7):S-45. PubMed ID: 11596575
    [No Abstract]   [Full Text] [Related]  

  • 8. Heparin-induced thrombocytopenia: diagnosis and management.
    Liebman HA
    Vascular; 2008; 16 Suppl 1():S71-6. PubMed ID: 18544310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies to heparin-platelet factor 4 complex: pathogenesis, epidemiology, and management of heparin-induced thrombocytopenia in hemodialysis.
    Davenport A
    Am J Kidney Dis; 2009 Aug; 54(2):361-74. PubMed ID: 19481318
    [No Abstract]   [Full Text] [Related]  

  • 10. Laboratory testing for heparin-induced thrombocytopenia: a conceptual framework and implications for diagnosis.
    Warkentin TE; Greinacher A; Gruel Y; Aster RH; Chong BH;
    J Thromb Haemost; 2011 Dec; 9(12):2498-500. PubMed ID: 22947414
    [No Abstract]   [Full Text] [Related]  

  • 11. Fondaparinux thromboprophylaxis-associated heparin-induced thrombocytopenia syndrome complicated by arterial thrombotic stroke.
    Salem M; Elrefai S; Shrit MA; Warkentin TE
    Thromb Haemost; 2010 Nov; 104(5):1071-2. PubMed ID: 20806120
    [No Abstract]   [Full Text] [Related]  

  • 12. The pathophysiology of heparin-induced thrombocytopenia: biological basis for treatment.
    Kelton JG
    Chest; 2005 Feb; 127(2 Suppl):9S-20S. PubMed ID: 15706026
    [No Abstract]   [Full Text] [Related]  

  • 13. High ANTI-PF4/Heparin Antibodies Titer and Thromboses Due to Infection 9 Months After Cessation of Heparin in Hemodialyzed Patient With Heparin-Induced Thrombocytopenia.
    Sain M; Burilovic V; Tomicic M; Jelicic I
    Ther Apher Dial; 2018 Oct; 22(5):558-559. PubMed ID: 29856115
    [No Abstract]   [Full Text] [Related]  

  • 14. Fondaparinux-related thrombocytopenia in a patient with former HIT. Response to Rota et al. (Thromb Haemost 2008; 99: 779-781).
    Schindewolf M; Lindhoff-Last E
    Thromb Haemost; 2008 Jul; 100(1):168-9; author reply 169-70. PubMed ID: 18612559
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of heparin-induced thrombocytopenia.
    Greinacher A
    Thromb Haemost; 1999 Aug; 82(2):457-67. PubMed ID: 10605737
    [No Abstract]   [Full Text] [Related]  

  • 16. Functional characterization of antibodies against heparin-platelet factor 4 complex in heparin-induced thrombocytopenia patients in Asian-Indians: relevance to inflammatory markers.
    Kannan M; Ahmad S; Ahmad F; Kale S; Hoppensteadt DA; Fareed J; Saxena R
    Blood Coagul Fibrinolysis; 2005 Oct; 16(7):487-90. PubMed ID: 16175007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-platelet factor 4/heparin antibodies in patients with impaired graft function after liver transplantation.
    Bakchoul T; Assfalg V; Zöllner H; Evert M; Novotny A; Matevossian E; Friess H; Hartmann D; Hron G; Althaus K; Greinacher A; Hüser N
    J Thromb Haemost; 2014 Jun; 12(6):871-8. PubMed ID: 24655935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin-induced thrombocytopenia.
    Greinacher A; Fürll B; Selleng S
    Methods Mol Biol; 2013; 992():301-18. PubMed ID: 23546723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin-induced thrombocytopenia in the cardiac patient: 10 points to help the physician.
    Rice L
    Methodist Debakey Cardiovasc J; 2011; 7(4):6-9. PubMed ID: 22143469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed-onset heparin-induced thrombocytopenia and cerebral thrombosis after a single administration of unfractionated heparin.
    Warkentin TE; Bernstein RA
    N Engl J Med; 2003 Mar; 348(11):1067-9. PubMed ID: 12637624
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.